SECT-B
|
Sectra AB (publ)
|
0.34%
|
SE
|
ST
|
ONT
|
Oxford Nanopore Technologies Ltd
|
0.34%
|
UK
|
LSE
|
PME
|
Pro Medicus Limited
|
0.33%
|
AU
|
ASX
|
PACB
|
Pacific Biosciences of California, Inc.
|
0.32%
|
US
|
NASDAQ
|
GLPG
|
Galapagos NV
|
0.31%
|
NL
|
AS
|
IDIA
|
Idorsia Ltd
|
0.29%
|
CH
|
SW
|
CERT
|
Certara, Inc.
|
0.29%
|
US
|
NASDAQ
|
326030
|
Sk Biopharmaceuticals Co Ltd
|
0.28%
|
KR
|
KO
|
ABCL
|
AbCellera Biologics Inc.
|
0.28%
|
US
|
NASDAQ
|
RCM
|
R1 RCM Inc.
|
0.28%
|
US
|
NASDAQ
|
XNCR
|
Xencor, Inc.
|
0.27%
|
US
|
NASDAQ
|
AGIO
|
Agios Pharmaceuticals, Inc.
|
0.27%
|
US
|
NASDAQ
|
CHEMM
|
ChemoMetec A/S
|
0.26%
|
DK
|
CO
|
VCYT
|
Veracyte, Inc.
|
0.26%
|
US
|
NASDAQ
|
3347
|
Hangzhou Tigermed Consulting Co Ltd
|
0.26%
|
HK
|
HK
|
302440
|
SK Bioscience Co Ltd
|
0.25%
|
KR
|
KO
|
VIVO
|
Meridian Bioscience Inc.
|
0.25%
|
US
|
NASDAQ
|
MRVI
|
Maravai LifeSciences Holdings, Inc.
|
0.25%
|
US
|
NASDAQ
|
CRVL
|
CorVel Corp.
|
0.25%
|
US
|
NASDAQ
|
NVRO
|
Nevro Corp.
|
0.24%
|
US
|
NYSE
|